Kadian

   
Google
 
Web NewDrugInformation.com

Kadian


Drug - Kadian
The trade name of the product as shown on the labeling.

Dosage - CAPSULE, EXTENDED RELEASE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Morphine Sulfate
Multiple ingredients are in alphabetical order.

Strength - 30MG
The potency of the active ingredient(s), Morphine Sulfate. May repeat for multiple part products.

Applicant - ALPHARMA US PHARMS
The firm name holding legal responsibility for Kadian. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020616
The FDA assigned number to Kadian. Format is nnnnnn.

Product Number - 004
The FDA assigned number to identify Kadian. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - BX
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Mar 9, 2001
The date Kadian was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Kadian. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Kadian is in. Format is RX, OTC, DISCN.

Applicant Full Name - Alpharma Us Pharmaceuticals Division
The full name of the firm holding legal responsibility for the new application of Kadian.

Kadian